← Eichor · All briefs

Signals

Weekly registry intelligence for biotech investors and analysts.

We monitor industry trials on ClinicalTrials.gov every day. Every Monday you'll receive a signed digest covering new trials, deterioration indicators, results-disclosure activity, FDA enforcement, accelerated-approval updates, and PMR/PMC changes — delivered when the public record changes, not when the press release arrives.

• Auditable by design — Every signal is backed by public registry or regulatory data with the source linked. Every digest is sealed in a cryptographically signed, tamper-evident ledger. No expert networks. No sponsor confidential information.
• Change-driven, not calendar-driven — Catalyst calendars tell you when scheduled events occur. Registry changes tell you when something actually changes.
• Scoped to your coverage — Monitor the therapeutic areas, sponsors, or watchlists that matter to you. Update your scope anytime.
• $999/month per seat — Cancel anytime. Designed for independent investors, research teams, and funds that need continuous public-record intelligence without enterprise pricing.

Get a free sample digest

The last two weeks of registry events in your scope — exactly what subscribers receive, no call, no card.

Built solely from public registry and filing data. Informational only — not investment advice or a recommendation to transact (see Terms).